For your reference as reviewers, please see the Abstract Submission Guidelines and Review Criteria
Late-Breaking Abstract deadline was 5:00 pm CDT on August 25, 2015.
All abstracts submitted to the SITC 30th Anniversary Annual Meeting are embargoed until
8:00 am EST on November 3, 2015.
To begin your review, log in below.
The 30th Anniversary Annual Meeting Abstract Submission Categories:
(all eligible for oral presentation consideration unless otherwise noted by the submitting author)
- Adoptive Immunotherapy
- Animal Models
- Basic Immunology
- Biomarkers
- CARs and T Cell Receptor Transduction
- Cutting-Edge Clinical Trials
- Clinical Studies
- Clinical Trials in Progress
- Coinhibition and Costimulation
- Dendritic Cells
- High Throughput Technologies
- Immune Modulation, Cytokines, Antibodies, and Immune Receptors
- Immune Monitoring
- Immune Suppression
- Immunogenomics and Oncogenetics
- Innate Immunity
- Mechanisms and Responses to Immune Therapy
- New Insight into T Cell Function
- Oncolytic Viruses
- Optimizing Combination Immunotherapy
- Other
- Precision Immunology
- Tumor Imaging
- Tumor Microenvironment
- Vaccines
For reference: Guidelines for Authors
Authors submitting an abstract to the SITC 30th Anniversary Annual Meeting must agree to the following:
- Serve as the contact for all correspondence about the abstract and inform co-authors about its status
- Confirm all authors are aware of and agree to the content and data presented in the abstract
- Verify the abstract is accurate and that permission has been obtained from all relevant parties
- Verify the data presented in the abstract has not been pubÂlished prior to the SITC 30th Anniversary Annual Meeting, or if previously published contains significant new data
- Agree that abstracts submitted to the SITC 30th Anniversary Annual Meeting are embargoed until 8:00 am EST on November 3, 2015
- Agree that, if accepted, the noted presenting author or a co-author will present the abstract at the 30th Anniversary Annual Meeting
